These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21495263)

  • 1. Impact of hyperlipidaemia on the orbital bone cefotaxime levels in rats.
    Panitsa G; Panitsas A; Potamianou A; Messari J; Vovou J; Tesseromatis C
    Eur J Drug Metab Pharmacokinet; 2010 Sep; 35(1-2):23-7. PubMed ID: 21495263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How harmless is FFA enhancement?
    Tesserommatis C; Tsopanakis C; Symeonoglou G; Loukissa M; Kouvarou E; Varonos DD
    Eur J Drug Metab Pharmacokinet; 1996; 21(3):213-5. PubMed ID: 8980917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.
    Arafat M; Kirchhoefer C; Mikov M
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):635-645. PubMed ID: 27686853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis).
    Sharma SK; Srivastava AK
    J Vet Sci; 2006 Jun; 7(2):119-22. PubMed ID: 16645334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.
    Béranger A; Oualha M; Urien S; Genuini M; Renolleau S; Aboura R; Hirt D; Heilbronner C; Toubiana J; Tréluyer JM; Benaboud S
    Clin Pharmacokinet; 2018 Jul; 57(7):867-875. PubMed ID: 28980166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity.
    Eyal A; Greif F; Shalit I; Lelcuk S
    Isr J Med Sci; 1996 Dec; 32(12):1317-9. PubMed ID: 9007180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime pharmacokinetics in Arabian camel (Camelus dromedarius) calves after single intravenous injection.
    Altayban A; Kandeel M; Tahoun A; Al-Nazawi M
    Trop Anim Health Prod; 2020 Mar; 52(2):887-891. PubMed ID: 31696417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked hyperlipidaemia in rats bearing the Yoshida AH-130 ascites hepatoma.
    Lopez-Soriano J; Argiles JM; Lopez-Soriano FJ
    Biochem Soc Trans; 1995 Aug; 23(3):492S. PubMed ID: 8566392
    [No Abstract]   [Full Text] [Related]  

  • 9. Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis.
    Hartman SJF; Boeddha NP; Ekinci E; Koch BCP; Donders R; Hazelzet JA; Driessen GJ; de Wildt SN
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1255-1260. PubMed ID: 30968258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin mitigates zidovudine-induced hepatocellular degenerative changes, oxidative stress and hyperlipidaemia in rats.
    Raghu R; Jesudas B; Bhavani G; Ezhilarasan D; Karthikeyan S
    Hum Exp Toxicol; 2015 Nov; 34(11):1031-42. PubMed ID: 25586000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antibacterial activity of cefotaxime and the penem HRE 664 in an improved in vitro model simulating serum and tissue pharmacokinetics.
    Isert D; Klesel N; Markus A; Seibert G; Schrinner E
    J Chemother; 1989 Jul; 1(4 Suppl):479-81. PubMed ID: 16312493
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of high plasma FFA induced by heparin during alimentary hyperlipaemia on platelets.
    Nordoy A; Strom E; Berntsen H
    Thromb Res; 1974 Jun; 4(0):suppl 1:71-2. PubMed ID: 4844008
    [No Abstract]   [Full Text] [Related]  

  • 13. Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.
    Maksoud E; Koehl B; Facchin A; Ha P; Zhao W; Kaguelidou F; Benkerrou M; Mariani P; Faye A; Lorrot M; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime.
    Dhalluin-Venier V; Bazin C; Massias L; Farah RB; Boytchev I; Fritsch J; Choury AD; Prat F; Buffet C; Furlan V; Pelletier G
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):127-30. PubMed ID: 18188033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy.
    van Zanten AR; Oudijk M; Nohlmans-Paulssen MK; van der Meer YG; Girbes AR; Polderman KH
    Br J Clin Pharmacol; 2007 Jan; 63(1):100-9. PubMed ID: 16869814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of plasma free fatty acid concentration on the content and composition of the free fatty acid fraction in rat skeletal muscles.
    Nawrocki A; Górski J
    Horm Metab Res; 2004 Sep; 36(9):601-6. PubMed ID: 15486810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and clinical efficacy of cefotaxime for the treatment of septicaemia in dogs.
    Sumano H; Gutierrez L; Ocampo L
    Acta Vet Hung; 2004; 52(1):85-95. PubMed ID: 15119790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipemia and heparin on free fatty acid content of rat plasma.
    GROSSMAN MI; PALM L; BECKER GH; MOELLER HC
    Proc Soc Exp Biol Med; 1954 Nov; 87(2):312-5. PubMed ID: 13237228
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes.
    Ling SS; Magosso E; Khan NA; Yuen KH; Barker SA
    Drug Dev Ind Pharm; 2006 Mar; 32(3):335-45. PubMed ID: 16556538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental and clinical study of antibiotics administered intravitreally in endophthalmitis].
    Shenderovich VA; Gusev IuA; Vlasova IV; Ved'mina EA; Kokurina EA
    Antibiot Khimioter; 1995 Sep; 40(9):38-41. PubMed ID: 8651829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.